Adoptive cell therapy with autologous. ex vivo-expanded. tumor-infiltrating lymphocytes (TILs) is being investigated for treatment of solid tumors and has shown robust responses in clinical trials. Based on the encouraging efficacy. https://www.duospiritalis.com/